Page 150 - 《中国药房》2026年8期

tical%20development%20of%20medicines%20for%20pae‐ C K. Modern pediatric formulations of the soft candies in
diatric，Categories%3A%20Quality%20%7C%20Pharma‐ the form of a jelly：determination of metoclopramide con‐
ceutical%20development%20TGA%20annotations%3A% tent and dissolution[J]. Pharm Dev Technol，2020，25（1）：
20Nil. 20-27.
[10] 丛端端，孙艳喆，耿莹，等. 浅谈儿童用药的口感设计和 [24] LIU F，RANMAL S，BATCHELOR H K，et al. Patient-
评价[J]. 中国医药工业杂志，2022，53（11）：1659-1663. centered pharmaceutical design to improve acceptability
[11] 苏昕玥，杨艳君，朱毛毛，等. 适用儿科制剂的辅料创新 of medicines：similarities and differences in paediatric and
研究技术体系、策略与发展趋势[J]. 中国中药杂志， geriatric populations[J]. Drugs，2014，74（16）：1871-1889.
2022，47（21）：5700-5707. [25] SAITO J，SHOJI K，MIYAIRI I，et al. Drug formulation
[12] SAITO J，AGRAWAL A，PATRAVALE V，et al. The cur‐ for pediatric oral antimicrobial agents in Japan：current sta‐
rent states，challenges，ongoing efforts，and future perspec‐ tus，prospects，and challenges[J]. Pediatr Infect Dis J，
tives of pharmaceutical excipients in pediatric patients in 2023，42（8）：e298-e303.
each country and region[J]. Children，2022，9（4）：453. [26] SHAH H S，SYAMALA U，CHAUDHARI K，et al. Pro‐
[13] WIEDEY R，KOKOTT M，BREITKREUTZ J. Orodis‐ cess modelling，scale-up and characterization of aceta-
persible tablets for pediatric drug delivery：current chal‐ minophen spray dried milk powder as novel pediatric
lenges and recent advances[J]. Expert Opin Drug Deliv， dosage form[J]. Pharm Res，2022，39（11）：2885-2903.
2021，18（12）：1873-1890. [27] KEAN E A，ADELEKE O A. A child-friendly anti-
[14] THABET Y，WALSH J，BREITKREUTZ J. Flexible and infective gummy formulation： design，physicochemical，
precise dosing of enalapril maleate for all paediatric age micromechanical，and taste sensory evaluation[J]. Drug
groups utilizing orodispersible minitablets[J]. Int J Pharm， Deliv Transl Res，2024，14（5）：1319-1337.
2018，541（1/2）：136-142. [28] MAWAZI S M，AL-MAHMOOD S M A，CHATTERJEE
[15] EDUARDO D T，ANA S E，JOSÉ B F. A micro-extrusion B，et al. Carbamazepine gel formulation as a sustained re‐
3D printing platform for fabrication of orodispersible lease epilepsy medication for pediatric use[J]. Pharmaceu‐
printlets for pediatric use[J]. Int J Pharm，2021，605： tics，2019，11（10）：488.
120854. [29] 王洋洋，佟若菲，孙燕燕，等. 我国与欧盟儿童非处方药
[16] ÖZYıLMAZ E D，COMOGLU T. Development of pedia- （化学药品单方制剂）适宜剂型与规格对比研究[J]. 药物
tric orally disintegrating mini-tablets containing atomo- 评价研究，2025，48（9）：2401-2408.
xetine hydrochloride- β -cyclodextrin inclusion complex [30] STRICKLEY R G. Pediatric oral formulations：an updated
using experimental design[J]. Drug Dev Ind Pharm，2022， review of commercially available pediatric oral formula‐
48（11）：667-681. tions since 2007[J]. J Pharm Sci，2019，108（4）：1335-1365.
[17] ZUCCARI G，ALFEI S，MARIMPIETRI D，et al. Mini- [31] WALSH J，BICKMANN D，BREITKREUTZ J，et al. De‐
tablets：a valid strategy to combine efficacy and safety in livery devices for the administration of paediatric formula‐
pediatrics[J]. Pharmaceuticals，2022，15（1）：108. tions： overview of current practice，challenges and recent
[18] KLINGMANN V. Acceptability of mini-tablets in young developments[J]. Int J Pharm，2011，415（1/2）：221-231.
children：results from three prospective cross-over studies [32] YIN H S，PARKER R M，SANDERS L M，et al. Liquid
[J]. AAPS PharmSciTech，2017，18（2）：263-266. medication errors and dosing tools：a randomized con‐
[19] KLINGMANN V，LINDERSKAMP H，MEISSNER T，et trolled experiment[J]. Pediatrics，2016，138（4）：e20160357.
al. Acceptability of multiple uncoated minitablets in in‐ [33] RAWAT S S，RAI A，RATHI R，et al. Medicated straw：an
fants and toddlers：a randomized controlled trial[J]. J Pe- innovative drug delivery system for paediatrics[J]. Expert
diatr，2018，201：202-207. Opin Drug Deliv，2023，20（3）：313-314.
[20] GUPTA M S，KUMAR T P，GOWDA D V，et al. Orodis‐ [34] HEJDUK A，LULEK J. Dispensing of minitablets： has
persible films： conception to quality by design[J]. Adv the problem been resolved[J]. Int J Pharm，2022，619：
Drug Deliv Rev，2021，178：113983.
121666.
[21] KLINGMANN V，POHLY C E，MEISSNER T，et al. Ac‐ [35] MALKAWI W A，ALRAFAYAH E，ALHAZABREH M，
ceptability of an orodispersible film compared to syrup in
et al. Formulation challenges and strategies to develop pe‐
neonates and infants：a randomized controlled trial[J]. Eur diatric dosage forms[J]. Children，2022，9（4）：488.
J Pharm Biopharm，2020，151：239-245.
[36] MFOAFO K A，OMIDIAN M，BERTOL C D，et al. Neo‐
[22] CHACHLIOUTAKI K，TZIMTZIMIS E K，TZETZIS D， natal and pediatric oral drug delivery： hopes and hurdles
et al. Electrospun orodispersible films of isoniazid for pe‐
[J]. Int J Pharm，2021，597：120296.
diatric tuberculosis treatment[J]. Pharmaceutics，2020，12
（收稿日期：2025-10-27 修回日期：2026-04-08）
（5）：470.
（编辑：孙 冰）
[23] KARAISKOU S G，KOUSKOURA M G，MARKOPOULOU

· 1104 · China Pharmacy 2026 Vol. 37 No. 8 中国药房 2026年第37卷第8期